
Sign up to save your podcasts
Or


Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Scott M. Cheney, M.D.
Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
268268 ratings
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Scott M. Cheney, M.D.
Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

139 Listeners

318 Listeners

699 Listeners

499 Listeners

251 Listeners

260 Listeners

3,348 Listeners

1,156 Listeners

196 Listeners

90 Listeners

512 Listeners

363 Listeners

12 Listeners

253 Listeners

18 Listeners

15 Listeners

9 Listeners

427 Listeners

372 Listeners

45 Listeners

14 Listeners